Trial Profile
A phase 2, multicenter, open label study of the safety and efficacy of high-dose pulse administration DN-101 (calcitriol) in patients with myelodysplastic syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.